Acclaro Medical | $23,000,000 | (May 30, 2025)
FarmQA, Inc | $4,000,000 | (May 30, 2025)
Uplinq | $10,000,000 | (May 30, 2025)
Certified by Founder
Lodge
Vima Therapeutics
start up
United States
- Cambridge, Massachusetts
- 30/05/2025
- Series A
- $60,000,000
Vima Therapeutics is a clinical-stage biotechnology company pioneering a new era in the treatment of dystonia and related movement disorders.
We are advancing VIM0423, a potential first-in-class oral therapy for dystonia, with the goal of helping individuals regain control of their movements by targeting the underlying cause of the disease.
Vima brings together a team of physicians, scientists, and drug developers with deep expertise in movement disorders and a shared commitment to deliver a meaningful oral therapy for patients.
- Industry Biotechnology Research
- Website https://vimatx.com/
- LinkedIn https://www.linkedin.com/company/vima-therapeutics/
KhiladiPro | $1,000,000 | (May 30, 2025)
LovOn | $850,000 | (May 30, 2025)
Volteras | $11,100,000 | (May 30, 2025)
ROXFIT | $1,077,281 | (May 30, 2025)
CurifyLabs | $7,594,115 | (May 30, 2025)
Outcomes4Me | $21,000,000 | (May 30, 2025)
Dream Park Immersive | $1,100,000 | (May 30, 2025)
Unbound(US) | $4,000,000 | (May 30, 2025)
Rime Labs | $5,500,000 | (May 30, 2025)